The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Localization of Vasopressin Binding Sites in Rat Tissues Using Specific Vi and V2 Selective Ligands*
Abstract
Arginine vasopressin (AVP) acts on at least two receptor types, classified on the basis of their second messengers. The V1 receptor acts via mobilization of intracellular calcium through phosphatidylinositol hydrolysis and influences blood pressure and hepatic glycogenolysis. The V2 receptor acts via cAMP through activation of adenylate cyclase and causes antidiuresis. Previous studies of the different AVP receptors have been hampered by the use of nonselective radioligands, such as [3H]AVP (which binds to all types of V1 and V2 receptors, certain oxytocin receptors, and neurophysins) as well as the difficulty of measurement of second messengers. This paper describes the use of selective V1 and V2 radioligands with in vitro autoradiography to study V1 and V2 binding sites in rat tissues. [125I][1-(beta-mercapto-beta,beta-cyclopentamethylene propionic acid), 7-sarcosine] arginine vasopressin ([125I][d(CH2)5,Sarcosine7]AVP), a selective V1 antagonist radioligand, bound to regions of the brain, testis, superior cervical ganglion, liver, blood vessels, and renal medulla. Pharmacological characterization of [125I][d(CH2)5,Sarcosine7]AVP binding was consistent with that expected for binding to V1 receptors. There was no specific binding demonstrable to pituitary, renal glomeruli, gut, heart, spinal cord, ovary, adrenal medulla, or adrenal cortex. [3H]1-deamino [8-D-arginine] vasopressin [( 3H]DDAVP), a potent V2 receptor agonist radioligand, was used to study V2 receptors. Specific binding was only identified in the kidney consistent with the known distribution of antidiuretic V2 receptors on renal collecting tubules. No binding was demonstrated on endothelium or liver where DDAVP might influence clotting factor release, nor in the brain, spinal cord, sympathetic ganglia, heart or vascular smooth muscle, regions where DDAVP might cause vasodilatation. These studies demonstrate the use of these radioligands to study V1 and V2 receptors in a variety of tissues. Also, since these ligands are selective they are of particular use to study the different receptor subtypes in tissues where V1 and V2 receptors coexist, such as in the kidney.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A causal link between vasopressin and glucose homeostasis is plausible because vasopressin induces gluconeogenesis in the rat liver and transiently increases glycemia in healthy humans and because vasopressin receptors are expressed in hepatocytes and pancreatic islets (2–9).”
From Low Water Intake and Risk for New-Onset Hyperglycemia (2011) · cites this paper as [6]
In the citing paper
“A causal link between vasopressin and glucose homeostasis is plausible because vasopressin induces gluconeogenesis in the rat liver and transiently increases glycemia in healthy humans and because vasopressin receptors are expressed in hepatocytes and pancreatic islets (2–9).”
From Low Water Intake and Risk for New-Onset Hyperglycemia (2011) · cites this paper as [6]
In the citing paper
“A causal link between vasopressin and glucose homeostasis is plausible because vasopressin induces gluconeogenesis in the rat liver and transiently increases glycemia in healthy humans and because vasopressin receptors are expressed in hepatocytes and pancreatic islets (2–9).”
From Low Water Intake and Risk for New-Onset Hyperglycemia (2011) · cites this paper as [6]
In the citing paper
“A causal link between vasopressin and glucose homeostasis is plausible because vasopressin induces gluconeogenesis in the rat liver and transiently increases glycemia in healthy humans and because vasopressin receptors are expressed in hepatocytes and pancreatic islets (2–9).”
From Low Water Intake and Risk for New-Onset Hyperglycemia (2011) · cites this paper as [6]
Citations
Cites
LIGAND: A versatile computerized approach for characterization of ligand-binding systems
Munson, P. J., & Rodbard, D. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90515-1 · Cited by 8,373
Tribollet, E., Barberis, C., Jard, S., Dubois-Dauphin, M., & Dreifuss, J. J. (1988) · Brain Research · doi:10.1016/0006-8993(88)91437-0 · Cited by 442
Michell, R. H., Kirk, C. J., & BILLAH, M. M. (1979) · Biochemical Society Transactions · doi:10.1042/bst0070861 · Cited by 440
Ausiello, D. A., Kreisberg, J. I., Roy, C., & Karnovsky, M. J. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109723 · Cited by 401
Jard, S., Gaillard, R. C., Guillon, G., Marie, J., Schoenenberg, P., Muller, A. F., Manning, M., & Sawyer, W. H. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10336-2 · Cited by 276
Matsuguchi, H., Sharabi, F. M., Gordon, F. J., Johnson, A. K., & Schmid, P. G. (1982) · Neuropharmacology · doi:10.1016/0028-3908(82)90012-0 · Cited by 196
Isolation of Glomeruli from Mammalian Kidneys by Graded Sieving
Misra, R. (1972) · American Journal of Clinical Pathology · doi:10.1093/ajcp/58.2.135 · Cited by 173
Chapter 16 Neurohypophyseal hormone receptor systems in brain and periphery
Jard, S., Barberis, C., Audigier, S., & Tribollet, E. (1987) · Progress in brain research · doi:10.1016/s0079-6123(08)60206-x · Cited by 164
de la FUENTE, B., KASPER, C. K., RICKLES, F. R., & HOYER, L. W. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-1-6 · Cited by 161
Audigier, S., & Barberis, C. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03794.x · Cited by 156
Cited by
Sorted by citations
Items 101–127 of 127
Vasopressin: a possible link between hypoxia and hypertension
Szczepanska‐Sadowska, E. K., & Żera, T. (2022) · Exploration of Medicine · doi:10.37349/emed.2022.00103 · Cited by 2
Verbalis, J. G. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00049-8 · Cited by 3
Vasopressin Receptors in Blood Vessels and Proliferation of Endotheliocytes
Khegay, I. I. (2021) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162021040129 · Cited by 2
CHARACTERIZATION OF MONOCLONAL ANTIBODIES TO A RAT LIVER VASOPRESSIN RECEPTOR
Trinder, D., Mooser, V., Kelly, J. M., Phillips, P. A., CASLEY, D. J., & Johnston, C. I. (1991) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1991.tb01460.x · Cited by 2
Self-citationGumerova, A. A., Pevnev, G., Korkmaz, F., Cheliadinova, U., Burganova, G., Vasilyeva, D., Cullen, L., Barak, O., Sultana, F., Zhou, W., et al. (2026) · eLife · doi:10.7554/elife.105355.3 · Cited by 2
Reaction of Rat Renal Medullary Laminin to Prolonged Dehydration
Khegay, I. I. (2023) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093023040221 · Cited by 1
Renal Effects of Neurohypophyseal Peptides
Verbalis, J. G. (2006) · Elsevier eBooks · doi:10.1016/b978-012369442-3/50172-0 · Cited by 1
Hormonal events and spinal cord injury: A focus on vasopressin and natriuretic peptide
Gumbel, J. H., & Hubscher, C. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822427-4.00024-1 · Cited by 1
ISOLATION AND CHARACTERIZATION OF THE RAT LIVER AVP RECEPTOR USING [125I][d(CH2)5′SARCOSINE7]AVP1
Trinder, D., Kelly, J. M., Fernley, R. T., Mooser, V., Phillips, P. A., & Johnston, C. I. (1992) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1992.tb00447.x · Cited by 1
Self-citationRelationship between pain and anxiety in rats
Roeska, K. (2010) · Gutenberg Open Science · doi:10.25358/openscience-1591 · Cited by 1
Investigations of potential mechanisms underlying spinal cord injury-induced polyuria.
Gumbel, J. H. (2021) · doi:10.18297/etd/3739 · Cited by 1
Expression and targeting of voltage-gated Ca2+ channels in neuroendocrine cells and pituicytes
Wang, D. D. (2010) · University Library - University of Saskatchewan (University of Saskatchewan)
Bäckström, T. (2008) · Uppsala University Publications (Uppsala University)
En búsqueda del Santo Grial Capítulo tres
Perrone, S. V. (2014) · Redalyc (Universidad Autónoma del Estado de México)
MONOCLONAL ANTIBODIES TO ARGININE VASOPRESSIN RECEPTOR BIND TO LIVER, KIDNEY AND PITUITARY MEMBRANES
Trinder, D., Mooser, V., Phillips, P. A., Smith, A. I., CASLEY, D. J., & Johnston, C. I. (1993) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1993.tb01722.x
Self-citationV1-like [Arg8]vasopressin binding sites occur in rat hepatocyte nuclei
Phillips, P. A., Hutchins, A., Burrell, L. M., Risvanis, J., & Johnston, C. I. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90662-9
Self-citationContribution to the understanding of nephrotoxic mechanisms
Jennings, P., Koppelstätter, C., Helbert, M. J. F., & Pfaller, W. (2003)
The biology of arginine vasopressin in cardiovascular disease
Jordan, L. V. M. (2003) · Enlighten: Theses (The University of Glasgow)
Iqbal, J. (1995) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/rtd-180813-10084
Reaction of Kidney Medullary Laminin to Prolonged Dehydration of Rats
Khegay, I. I. (2023) · Российский физиологический журнал им И М Сеченова · doi:10.31857/s0869813923070051
Gumerova, A. A., Pevnev, G., Korkmaz, F., Cheliadinova, U., Burganova, G., Vasilyeva, D., Cullen, L., Barak, O., Sultana, F., Zhou, W., et al. (2026) · eLife · doi:10.1101/2024.12.09.627541 · Cited by 1
Gumerova, A. A., Pevnev, G., Korkmaz, F., Cheliadinova, U., Burganova, G., Vasilyeva, D., Cullen, L., Barak, O., Sultana, F., Zhou, W., et al. (2025) · eLife · doi:10.7554/elife.105355.1
Gumerova, A. A., Pevnev, G., Korkmaz, F., Cheliadinova, U., Burganova, G., Vasilyeva, D., Cullen, L., Barak, O., Sultana, F., Zhou, W., et al. (2025) · eLife · doi:10.7554/elife.105355 · Cited by 1
Knepper, M. A., Valtin, H., & Sands, J. M. (1999) · Comprehensive physiology · doi:10.1002/j.2040-4603.1999.tb01499.x
Gumerova, A. A., Pevnev, G., Korkmaz, F., Cheliadinova, U., Burganova, G., Vasilyeva, D., Cullen, L., Barak, O., Sultana, F., Zhou, W., et al. (2026) · eLife · doi:10.7554/elife.105355.2
New regulators in oxytocin and vasopressin release : role of the endolysosomal two-pore channels
Martucci, L. L. (2021) · theses.fr (ABES) · doi:10.70675/027d1ae2zd2ebz4677za019ze6ccd94cafe9
Metadata
- Authors
- PHILLIPS, P. A., ABRAHAMS, J. M., KELLY, J. M., MOOSER, V., TRINDER, D., & JOHNSTON, C. I.
- Affiliations
- The University of Melbourne (AU)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1990-03
- Volume
- 126
- Issue
- 3
- Pages
- 1478-1484
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W1997729156
- Cited by
- 127
- References
- 33
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 5 · 2020: 1 · 2019: 2 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 2
- FWCI
- 16.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Surgery › Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Keywords
- V1 receptor, V2 receptor, receptor localization, desmopressin, vasopressin, in vitro autoradiography, rat tissues, receptor subtypes
- MeSH terms
- Animals, Autoradiography, Binding Sites, Blood Vessels, Brain, Kidney Glomerulus, Ligands, Liver, Membranes, Rats, Inbred Strains, Vasopressins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
